Metabolic disorders

assortment of ice cream flavors
Biotech

JPM: Novo CSO craves 'different flavors' of pipeline innovation

Novo is seeking to strengthen its obesity offerings while pursuing other indications that intersect with metabolism.
Darren Incorvaia Jan 13, 2026 7:45am
graphic of a larger shark chomping up a smaller one

Cardiometabolic field drives M&A while cancer deals drop: report

Oct 27, 2025 2:39pm
patent infringement patent lawsuit

Arrowhead sues Ionis over patent dispute for Tryngolza rival

Sep 11, 2025 11:33am
liver

FDA considers new liver trial endpoint, sending MASH shares up

Aug 28, 2025 11:25am
Measuring tape on top of cash

Novo seeks obesity refresh with $550M Replicate deal

Aug 28, 2025 7:00am
dominoes stop stall halt end red

Terns vows to stop funding metabolic disease trials beyond 2025

Aug 6, 2025 6:20am